HLB Therapeutics Co (XKRX:115450) Price-to-Operating-Cash-Flow : 142.22 (As of May. 12, 2024)

View and export this data going back to 2010. Start your Free Trial

What is HLB Therapeutics Co Price-to-Operating-Cash-Flow?

As of today (2024-05-12), HLB Therapeutics Co's share price is ₩9340.00. HLB Therapeutics Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩65.67. Hence, HLB Therapeutics Co's Price-to-Operating-Cash-Flow Ratio for today is 142.22.

The historical rank and industry rank for HLB Therapeutics Co's Price-to-Operating-Cash-Flow or its related term are showing as below:

XKRX:115450' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 50.16 Med: 184.63 Max: 1278.29
Current: 142.22

During the past 13 years, HLB Therapeutics Co's highest Price-to-Operating-Cash-Flow Ratio was 1278.29. The lowest was 50.16. And the median was 184.63.

XKRX:115450's Price-to-Operating-Cash-Flow is ranked worse than
90.24% of 297 companies
in the Biotechnology industry
Industry Median: 26.92 vs XKRX:115450: 142.22

HLB Therapeutics Co's Cash Flow from Operations per share for the three months ended in Dec. 2023 was ₩161.36. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 was ₩65.67.

During the past 13 years, HLB Therapeutics Co's highest 3-Year average Operating Cash Flow per Share Growth Rate was 40.30% per year. The lowest was -39.80% per year. And the median was -7.05% per year.

HLB Therapeutics Co Price-to-Operating-Cash-Flow Historical Data

The historical data trend for HLB Therapeutics Co's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HLB Therapeutics Co Price-to-Operating-Cash-Flow Chart

HLB Therapeutics Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

94.82

HLB Therapeutics Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	55.06	-	-	94.82

Competitive Comparison of HLB Therapeutics Co's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, HLB Therapeutics Co's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

HLB Therapeutics Co's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, HLB Therapeutics Co's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where HLB Therapeutics Co's Price-to-Operating-Cash-Flow falls into.

HLB Therapeutics Co Price-to-Operating-Cash-Flow Calculation

HLB Therapeutics Co's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	9340.00	/	65.672
	=	142.22

HLB Therapeutics Co's Share Price of today is ₩9340.00.
HLB Therapeutics Co's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩65.67.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

HLB Therapeutics Co Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of HLB Therapeutics Co's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

HLB Therapeutics Co (XKRX:115450) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » HLB Therapeutics Co Ltd (XKRX:115450) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

22F, Parkview Tower, 6, Jeongja-Dong, Bundang-Gu, Seongnam-si, 463-863, KOR, 463-811

Website

https://www.hlbtherapeutics.co.kr

HLB Therapeutics Co Ltd is a bio company that pursues first-in-class and innovates new drug development. With the development and validation of new drugs for various hard-to-treat disorders, HLB Therapeutics is becoming a global biopharmaceutical company focused on alleviating patient suffering.

HLB Therapeutics Co (XKRX:115450) Headlines

No Headlines